Results 101 to 110 of about 669 (133)

Sapropterin dihydrochloride for phenylketonuria and tetrahydrobiopterin deficiency

open access: yesExpert Review of Endocrinology and Metabolism, 2010
Sapropterin dihydrochloride is the first registered synthetic form of the naturally occurring cofactor and cosubstrate, tetrahydrobiopterin (BH4). It is essential for the conversion of phenylalanine (Phe) by phenylalanine-4-hydroxylase (PAH) to tyrosine.
Nenad Blau
exaly   +4 more sources

International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria [PDF]

open access: yesMolecular Genetics and Metabolism, 2019
Phenylketonuria (PKU) is an inherited metabolic disease caused by phenylalanine hydroxylase (PAH) deficiency. As the resulting high blood phenylalanine (Phe) concentration can have detrimental effects on brain development and function, international guidelines recommend lifelong control of blood Phe concentration with dietary and/or medical therapy ...
Ania C Muntau   +2 more
exaly   +8 more sources

Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria

open access: yesAmerican Journal of Medical Genetics, Part A, 2008
AbstractPhenylketonuria (PKU) is an inherited metabolic disease characterized by phenylalanine (Phe) accumulation, which can lead to neurocognitive and neuromotor impairment. Sapropterin dihydrochloride, an FDA‐approved synthetic formulation of tetrahydrobiopterin (6R‐BH4, herein referred to as sapropterin) is effective in reducing plasma Phe ...
Jon Wolff   +2 more
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

Sapropterin Dihydrochloride Tablets

Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy ...
Dennis J. Cada   +2 more
openaire   +1 more source

PP14 Budget Impact Of Sapropterin Dihydrochloride For Phenylketonuria

International Journal of Technology Assessment in Health Care, 2019
IntroductionThe National Committee for Health Technology Incorporation (CONITEC) evaluates health technologies to recommend their inclusion or exclusion within the Brazilian Public Health System (SUS), and uses the budget impact assessment to estimate costs to the system.
Eduardo Mulinari   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy